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ScienceDirectBacterial, viral and parasitic zoonotic pathogens that transmit
via the fecal-oral route have a major impact on global health.
However, the mechanisms underlying the emergence of such
pathogens from the animal reservoir and their persistence in the
human population are poorly understood. Here, we present a
framework of human-to-human transmission of zoonotic
pathogens that considers the factors relevant for fecal-oral
human-to-human transmission route at the levels of host,
pathogen, and environment. We discuss current data gaps and
propose future research directions.
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In recent years there have been many examples of patho-
gens crossing the species barrier and infecting humans,
although the vast majority of these zoonotic events did
not result in sustained human-to-human transmission [1–
3]. Nevertheless, the continuing emergence of zoonotic
pathogens is a cause of concern globally, especially due to
the high morbidity and mortality of pathogens like
MERS-CoV and A/H5N1 influenza virus [4,5]. Human-
to-human transmission of microorganisms generally
occurs via one or multiple transmission routes, including
the fecal-oral, airborne, direct contact, or vector-borne
route. Whilst pathogens including bacteria, parasites and
viruses have very different biological properties, they can
employ similar routes of transmission and emergence.
Identification of the mechanisms underlying the effective
human-to-human transmission of emerging zoonotic
pathogens and their commonalities across different
pathogens, may help design of interventions aimed at
reducing the risk of sustained human-to-human transmis-
sion after a zoonotic event.
Expert opinion meeting
As part of the activities of the ANTIGONE consortium
on the emergence of zoonotic pathogens, an expert opin-
ion meeting was organized. Using a comparative approach
including parasites, bacteria and viruses that transmit via
the fecal-oral route, the meeting aimed at identifying the
key drivers of sustained human-to-human transmission
after a zoonotic event, taking into account the host, the
pathogen and the interface (transmission amplifiers). In
addition, major knowledge gaps were identified that
require future research in order to better control emerging
zoonotic pathogens that potentially are transmitted
through a fecal-oral route. The main conclusions of this
meeting are presented in this perspective.
A framework of fecal-oral transmission
Enteric pathogens can be transmitted between humans
by the fecal-oral route via direct contact or indirect
contact via contaminated fluids, including surface water,
food, and carriers such as fomites (Figure 1). The risk of a
zoonotic pathogen becoming human-to-human transmis-
sible depends on its adaptation to the human host and the
environment. To analyze this process, we considered
fecal-oral transmission of a zoonotic pathogen betweenCurrent Opinion in Virology 2017, 22:1–6
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Fecal-oral transmission between humans. After shedding from the host enteric pathogens can be transmitted between humans by the fecal-oral
route via direct contact between humans, or via indirect contact via contaminated fluids, including surface water, food, and carriers such as
fomites.two human hosts as follows; the human host that is
infected with a zoonotic pathogen after a zoonotic event
is defined as the donor while the susceptible human host
that is subsequently infected by the first human host is
considered the recipient. The transmission interface is
the environment that the pathogen encounters after
release from the donor and before infecting the recipient.
For sustained fecal-oral human-to-human transmission
certain elements in this transmission cycle, which we will
refer to as transmission amplifiers, appear essential
whereas other elements are not an absolute requirement,
but increase the likelihood of transmission. Transmission
amplifiers may interact and their presence may or may not
depend on conditions under which transmission occurs,
including for example socio-economic conditions and
cultural and behavioral variation. We designed a frame-
work of human-to-human transmission that includes the
transmission amplifiers relevant for the fecal-oral trans-
mission route at the levels of host, pathogen, and envi-
ronment (Figure 2).Current Opinion in Virology 2017, 22:1–6 Transmission amplifiers specific for fecal-oral
transmission
Several key transmission amplifiers are specific for fecal-
oral transmission (Figure 2), such as the intestinal micro-
biomes of the donor and recipient hosts. Individuals with
a healthy intestine are less likely to become infected or
colonized by opportunistic pathogens, although the resis-
tance provided by a healthy colonization (microbiome)
can, in principle, be disrupted by a pathogenic species
depending on its pathogenic potential (virulence) [6,7].
The composition of the human intestinal microbiome is,
amongst others dependent on the presence of a functional
immune system [8–10]. Changes in microbiome compo-
sition, in addition to the impaired immunity itself, may
impact the outcome of infection and subsequent trans-
mission.
Clinical symptoms such as diarrhea and vomiting can
increase the likelihood of fecal-oral transmission as
they can facilitate the spread of a pathogen into thewww.sciencedirect.com
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Figure 2
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2. Transmission Amplifiers
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Framework for human-to-human transmission after a zoonotic event showing the key transmission amplifiers from the host (triangle), pathogen
(blue) and environmental transmission amplifiers (green), respectively. The transmission amplifiers that are specific to the fecal-oral route are
indicated with a red star.environment and onto fomites [11]. Remarkably, most
pathogens that transmit via the fecal-oral route are very
stable and can survive under various conditions, which
may be related to the fact that these pathogens have to
pass the hostile conditions of the gastrointestinal tract.
Zoonotic pathogens need to adapt to factors specific to
this niche, such as the acidic conditions in the stomach
and low oxygen in the large intestine, the temperature
and the availability of specific sugars and nutrients. For
example, comparative genomics of Cryptosporidium par-
vum genotype IIc suggests that the ability to establish
an infection in a particular host species may depend in
part on the presence of transporters controlling the
exchange of metabolites between the host cell and
the pathogen [12].
Fecal shedding of a pathogen does not necessarily require
replication in the intestine. For example, the hepatitis E
virus (HEV) is shed via the feces despite its liver tropism
[13]. However, the presence of receptors and the tissue
distribution of these receptors is a crucial element for
tropism of infection, the shedding of microorganisms in
stool and subsequent human-to-human transmission. In
addition, it should be noted that not all pathogens that arewww.sciencedirect.com shed via the feces transmit via the fecal-oral route. Several
respiratory viruses of zoonotic origin, that are capable of
human-to-human transmission, are shed in feces. During
SARS-CoV, MERS-CoV and influenza A infection, viral
RNA can be detected in stool. However, for these patho-
gens there is currently no evidence of fecal-oral transmis-
sion resulting in disease [14–19]. Similarly, the enteric
pathogen Campylobacter subspecies jejuni was transmitted
from human-to-human via sexual contact following a
zoonotic event [20].
Once a donor is shedding the pathogen, environmental
factors at the transmission interface can have a large
impact on transmission efficiency. Contamination of
the surface water after flooding can magnify the size of
an outbreak via waterborne and foodborne routes [21].
Food sources can be contaminated by irrigation with
sewage-contaminated water or the use of manure that
contains traces of human feces, or on site by food-hand-
lers. Anecdotally, even food preservation measures can
impact transmission as some additives to preserve lettuce
were shown to also increase the stability of hepatitis A
virus [22]. Transmission via food can have a major impact
on the global spread of pathogens. In 2011 nearlyCurrent Opinion in Virology 2017, 22:1–6
4 Emerging viruses: intraspecies transmission4000 people were infected during an Escherichia coli
O104:H4 outbreak in Europe, resulting in 54 deaths. Epi-
demiological and trace-back investigations pointed to salad
sprouts as the possible contaminated food source [23].
Transmission amplifiers not specific for fecal-
oral transmission route
Several factors that are important transmission amplifiers
of the likelihood of fecal-oral transmission are generic to
most human-to-human transmission routes.
The immune system of the human host is an important
factor that has to be confronted for sustained human-to-
human transmission. Most pathogens that successfully
transmit, have acquired genes that can counteract or evade
the adaptive and or innate immune responses. Pathogens
may have adapted through altered domains that are recog-
nized by the cellular or humoral immune system, to evade
pre-existing immunity based on previously infecting patho-
gens. Loss of genes or gene function may also be associated
with adaptation to the human host. A Salmonella enterica
serotype Typhimurium clone which causes bloodstream
infection amongst children and HIV-infected adults in
Sub-Saharan Africa, has adapted to these immuno-compro-
mised hosts through loss of gene functions enabling bacte-
rial survival outside the host, whilst retaining the ability to
cause enteritis in multiple host species [24].
With the general population aging and technologies be-
coming more invasive, medical interventions can become
an amplifier of human-to-human transmission. Although
medical interventions do not necessarily select for hu-
man-to-human transmissible pathogens, they can in-
crease the duration of infection, and thereby the
likelihood of evolution and adaptation [25]. For instance,
the application of extracorporeal membrane oxygenation
prolongs and increases survival in patients with otherwise
acute fatal infectious disease [26]. The use of immune
modulatory and suppressive drugs has created a human
population that is more susceptible to prolonged patho-
gen proliferation and shedding [27–31]. An immunode-
ficient individual was found to excrete a vaccine-derived
poliovirus for twenty years. During this time the virus
became virulent and changed antigenically [32]. The
unrestrained use of antimicrobial drugs in medical and
veterinary care and in agriculture in low-income, middle-
income, and high-income countries creates an unprece-
dented selective pressure that may select for pathogens
that are more transmissible. Salmonella enterica serotype
Typhimurium has the ability to develop a super shedder
phenotype, that can be induced by antibiotic treatment in
mice [33]. A human reservoir for non-typhoid Salmonella
(NTS) transmission of multiple serotypes was demon-
strated in a study of NTS-infected patients who contin-
ued to shed NTS for months up to years, and strains of
these patients acquired antimicrobial resistance genesCurrent Opinion in Virology 2017, 22:1–6 and virulence genes that possibly affected host–pathogen
interactions [34].
The infectious dose, replication kinetics and the number
of pathogens being shed can have a major impact on the
efficiency of fecal-oral transmission. For example, noro-
virus and Shigella spp. require a low infectious dose and
can be transmitted via hands and fomites [35,36], whereas
Listeria monocytogenes infections require a high infectious
dose [37], making these transmission routes less likely.
However, surprisingly little is known about the infectious
dose for many fecal-orally transmitted human pathogens.
As for shedding in the environment, several strategies can
be successful, such as shedding of lower amounts of
microorganisms over a long period (chronic/persistent
infection) and thus a long period of transmission associ-
ated with mild clinical symptoms , or shedding of high
loads of microorganisms for a relatively short period with
significant clinical symptoms [36].
Receptor usage is a key element for successful human-to-
human transmission. Not only are the site of the expression
of these receptors in the host and the receptor specificity of
the pathogen of importance, but also the prevalence of
these receptors in the human population can potentially
contribute to the likelihood of efficient transmission. For
group A rotaviruses attachment to histobloodgroup antigens
is an essential step for infection. Interestingly, strains of the
P[9], P[14] and P[25] subtypes that are generally found in
cattle but can also infect humans, attach to the blood group
A epitope [38]. However, since the frequency of blood
group A in human populations ranges from 20% to 40%, the
majority of individuals is expected to be resistant to infec-
tion by these strains, which would constitute a barrier to
transmission. Sustained human-to-human transmission for a
virus with a relatively low R0 would thus require an adap-
tation of the glycan binding capacity to the human HBGA
genetic polymorphism [39]. HEV genotype 1 and 2 exclu-
sively infect humans while genotypes 3 and 4 infect pigs
but occasionally infect and transmit between humans [40].
The high conservation of HEV attachment and entry
factors may explain the observed cross-species transmission
while factors limiting efficient human-to-human transmis-
sion are thought to include regulation of subgenomic trans-
lation and specific virus–host receptor interactions [41,42].
Inherent differences between viruses,
bacteria, and parasites
Surprisingly few differences exist between the basic
requirements of the different types of pathogens to
become human-to-human transmissible. However, bac-
teria can replicate in the environment whereas viruses
and parasites cannot. As the transmittable stages of para-
sites are environmentally very resistant, and can with-
stand water treatment processes, parasites are probably
more likely to be transmitted via food and water com-
pared to direct fecal-oral-transmission [43,44]. Genomewww.sciencedirect.com
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parasites, viruses and bacteria can all adapt by mutations,
recombination and lateral gene transfer, viruses can also
acquire genes by genome rearrangements and bacteria
can acquire mobile genetic elements that carry genes that
may encode determinants that facilitate increased fitness
in certain conditions.
Synthesis
‘For a zoonotic pathogen the risk of becoming human-to-
human transmissible depends on further adaptation to the
human host. For efficient fecal-oral transmission ampli-
fiers in the transmission interface appear crucial.’
Knowledge gaps and outlook
The focus of the public health and emerging infectious
disease communities on emerging viruses causing severe
infections, has resulted in the discovery of several possible
determinants of sustained human-to-human transmission
of zoonotic viruses. However, the likelihood of sustained
human-to-human fecal-oral transmission after a zoonotic
event of any pathogen type is difficult to assess as these
events are hardly described in current literature. One
could conclude that zoonotic pathogens rarely become
human-to-human transmissible through the fecal-oral
route because there may be need for dual adaptation,
i.e. to the harsh conditions in the environment in addition
to the human host, and therefore these events are rare.
However, we cannot exclude that we may be missing some
of these events, because it can be difficult to distinguish
between strictly human and zoonotic pathogens once the
latter have established themselves in the human popula-
tion or because they remain undistinguished with the use
of current clinical microbiology tools. For example, recent
results strongly suggest that a pig roundworm can act as an
important source of human ascariasis [45–47] but this can
go unnoticed as the human and pig parasite population
show minor phenotypic and genotypic differences. Zoo-
notic pathogens that transmit via the fecal-oral route
appear to cause similar clinical symptoms compared to
other (related) enteric pathogens and further research is
not pushed due the relative lack of (more) serious disease.
We thus may neglect relevant pathogens and even if we do
study these pathogens, the results may have undesired
economic consequences for agriculture and food sectors.
In addition, until recently we lacked tools for studying
important zoonotic events; whilst the small genomes and
rapid evolution of viruses allow identification of novel
causative agents with limited sequencing effort, such
analysis is much more complicated for bacterial and para-
sitic enteric pathogens which have relatively large gen-
omes. Some experimental models for fecal-oral
transmission between hosts have been described, such
as for norovirus [48], but there is a general lack of
suitable animal models to study fecal-oral transmission.
In fact, most research on host-pathogen interactions is
focused on mechanisms of pathogenicity rather than onwww.sciencedirect.com mechanisms of transmission, whilst the latter is crucial for
the development of intervention strategies to prevent
further spread and to prevent sustained human-to-human
transmission of zoonotic pathogens.
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